Latest Headlines

  1. Insights From GRAM At CPHI Milan 2026: Navigating The Future Of Sterile Manufacturing 9/9/2026

    As biologics manufacturing evolves, Contract Development and Manufacturing Organizations (CDMOs) are becoming increasingly pivotal. At CPHI Milan, October 6 – 8, 2026, Grand River Aseptic Manufacturing (GRAM) will showcase its innovative capabilities, particularly in aligning manufacturing capacity and capabilities with clients’ long-term goals, at booth #8A26.

  2. Ardena To Attend CPHI Worldwide Milan 2026, Launching Charity Step Challenge "From Molecules To Miles" 9/9/2026

    Ardena, a full-service contract development and manufacturing organization (CDMO) supporting pharmaceutical companies from molecule to market, will participate in CPHI Worldwide, taking place October 6-8, 2026, in Milan, Italy.

  3. Lifecore Biomedical Signs Agreement For Commercial Site Transfer Supporting Global Pharmaceutical Company 9/2/2026

    Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced it has signed a new agreement to transfer a commercially marketed product to the company’s pipeline.

  4. AST Names Industry Veteran Jon Lenihan As Chief Commercial Officer 8/31/2026
  5. JHS And Altoura Selected For BioTools Innovator VANGUARD Level Up-XR Program 8/28/2026

    Jubilant HollisterStier(JHS) and Altoura will be of only three company-CDMO pairs participating in the BioTools Innovator VANGUARD Level Up-XR Program.

  6. Resilience And Lilly Invest $750 Million To Increase U.S.-Manufactured Medicine Supply 8/28/2026
  7. UCB Selects Gwinnett County For New U.S. Biologics Manufacturing Facility 8/20/2026

    UCB today announced that it has selected Gwinnett County, Georgia as the location for its new U.S. biologics manufacturing facility. The campus will be state-of-the art, using a digital-first approach by leveraging AI, robotics, and automation while being natural resources efficient. The project represents a major milestone in UCB’s previously announced U.S. expansion and reinforces the company’s long-term commitment to patients, innovation, and sustainable growth in one of its fastest-growing markets.

  8. Nordson MEDICAL Introduces The New Divert™ ULTRA Line Of Ultra-High- Pressure Stopcocks For Demanding Medical Applications 8/19/2026

    Nordson MEDICAL introduces Divert™ ULTRA, ultra-high-pressure stopcocks engineered for reliable flow control, ergonomic operation, and precision in demanding medical applications up to 1,500 psi.

  9. New Distek Software Simplifies Bioreactor Data Monitoring And Management 8/12/2026

    Distek, Inc., a leading manufacturer of bioprocessing equipment, announces the release of their BIOne Core Software, an advanced, cloud-based historian software platform designed exclusively for BIOne Bioprocess Controllers. Delivered as a Software-as-a-Service (SaaS) solution, BIOne Core enables users to easily visualize, monitor, and manage critical bioprocess data while minimizing on-premise IT infrastructure.

  10. ILC Dover Introduces EZJetFlo™ Technology To Transform Powder Dissolution And Mixing In Biopharmaceutical Manufacturing 8/7/2026